Elsevier, The Lancet, 10023(387), p. 1085-1093, 2016
DOI: 10.1016/s0140-6736(16)00143-4
Full text: Download
Lithium is a first-line treatment in bipolar disorder, but individual response is variable. Previous studies have suggested that lithium response is a heritable trait. However, no genetic markers of treatment response have been reproducibly identified.